Background {#Sec1}
==========

Surgical site infections (SSIs) are a major postoperative complication after abdominal surgery, especially in the colorectal field \[[@CR1]\]. With a reported incidence of over 20%, SSIs significantly increase the length of stay (LOS), readmission rate, expenses, and mortality \[[@CR2], [@CR3]\]. Therefore, the identification of an effective method of reducing SSI incidence is critically important \[[@CR4]\]. Colonic bacterial florae are considered to be the major cause of SSIs after elective colorectal procedures, but the most effective means of decreasing this bacterial load remains under debate \[[@CR5]\]. Preoperative mechanical bowel preparation (MBP) was first utilized by surgeons, as it can theoretically remove stool content and associated bacterial load within the bowel and surgical field, thus reducing the risk of SSIs \[[@CR6]\]. More recently, as antibiotics have come to be widely utilized, the preoperative administration of unabsorbed oral antibiotics (OAs) in combination with MBP was widely conducted \[[@CR2], [@CR7]\].

Multiple trials have been performed to explore the best bowel preparation strategies, but their results remain controversial \[[@CR8]--[@CR10]\]. Since 2005, several RCTs and meta-analyses have demonstrated MBP alone was not associated with a reduced incidence of SSIs related to patients that did not undergo MBP, whereas MBP patients exhibited paradoxical increases in postoperative ileus, anastomotic leakage, and other complications \[[@CR11]--[@CR14]\]. Recently, the merit of OA and MBP has been rediscovered in several related retrospective studies, which demonstrated a significant decrease in the rate of SSIs \[[@CR15]--[@CR17]\]. However, as information in these trials were exacted from national databases without any detailed matching between patient groups, the existence of bias in these trials may affect the validity of their results. Furthermore, none of these studies assessed the relative prophylactic effects of the novel MBP mode in right or left-side colorectal surgery. Herein, we report on our experiences in a single-center comparison of MBP + OA with MBP alone, assessing the rates of prophylactic combinations between groups via propensity score matching and stratification.

Method {#Sec2}
======

Study population {#Sec3}
----------------

This retrospective study was approved by the Ethics committee of the Third Affiliated Hospital of Sun Yat-sen University. Eligible patients were identified by searching the database of the Gastrointestinal Surgery Centre, Third Affiliated Hospital of Sun Yat-sen University from 2011 to 2017. Patient inclusion criteria were as follows: (1) patient underwent elective colorectal resection to treat a malignancy, (2) patient baseline characteristics and operative information were available, and (3) MBP was performed before surgery, with or without OA.

Patient exclusion criteria were as follows: (1) emergency surgery; (2) MBP was not conducted due to ileus or patient refusal; (3) enough data was not available; (4) colorectal resection was performed due to benign disease; (5) the procedure was accompanied by other procedures that had the potential to contaminate the incision, such as cholecystectomy or appendectomy; and (6) patients underwent neoadjuvant radiotherapy before surgery.

The primary and secondary aims of the study have been stated in the latest manuscript. The primary aim was to evaluate prophylactic function of preoperative OA combined with MBP vs MBP alone in postoperative SSI incidence. The secondary aim was to explore the potential benefit on length of hospital stays of OA + MBP mode compared with simple MBP.

Application of preoperative antibiotics was under surgeons' decisions; no patients withdrew during the study period. Either polyethylene glycol or magnesium sulfate was adopted as a laxative 1 day before surgery. Clyster was conducted on surgery morning. Streptomycin 1 g plus metronidazole 0.2 g was prescribed 3 times a day for 3 days before surgery in the OA + MBP group patients.

Intravenous antibiotic prophylaxis was based on local guidelines and resistance profiles: most of the patients received cefmetazole 2 g intravenous drip 30 min before incision and once every 12 h until 48 h after surgery. Patients with penicillin or cephalosporin allergy were given clindamycin 0.6 g twice a day. If the surgical procedure lasted more than 180 min, a booster dose of antibiotic was administered.

Outcomes {#Sec4}
--------

Based on the preparation procedures employed, patients were divided into a mechanical preparation plus oral antibiotics group (MBP + OA group) and a simple MBP group. The following demographic, clinical, and pathological information were extracted from the database: age, gender, BMI, comorbidities, American Society of Anesthesiologists (ASA) score, operative duration, laparoscopic or laparotomy approach, surgical site, neoadjuvant chemotherapy, combination with multi-organ resection, TNM stage, and preoperative serum albumin level. Outcomes of interest were length of hospital stay (LOS), expense, and rates of postoperative complications, which included anastomotic leakage, SSIs, postoperative ileus, respiratory/urinary infection, deep vein thrombosis (DVT), and postoperative *Clostridium difficile* infection (CDI).

Statistical analysis {#Sec5}
--------------------

Frequencies were presented for categorical variables, and means ± standard deviation were given for continuous variables. Pearson's *χ*^2^ or Fisher's exact tests were used to analyze categorical variables. Student's *t* tests were used for analyzing normally distributed data; otherwise, Mann-Whitney *U* tests were used for continuous variables. Propensity score matching was performed for minimizing confounding based on TNM stage, laparoscopic or laparotomy approach, ASA score, gender, BMI, and neoadjuvant chemotherapy. A multivariate logistic regression model was used to identify independent SSI risk factors, and a stepwise forward method was used for variable selection (inclusion *p* \< 0.05; permanence *p* \< 0.1). The fit for this logistic regression was tested with the Hosmer and Lemeshow test. All data analyses were performed with SPSS v22 (Armonk, NY: IBM Corp).

Result {#Sec6}
======

Unmatched patient characteristics {#Sec7}
---------------------------------

We analyzed retrospective data from a total of 806 patients between 2011 and 2017, using the database of the Third Affiliated Hospital of Sun Yat-Sen University. Of these patients, 581 met the inclusion criteria and were enrolled in our study (255 in the OA + MBP group and 326 in the MBP group). The average age was 59.78 ± 12.11 in the OA + MBP group and 59.22 ± 12.16 in the MBP group. The average BMI in these groups was 22.40 ± 3.59 and 22.93 ± 3.40, respectively. Male patients occupied 56.86% and 61.04% in each group. Colon cancer accounted for 94.12% and 72.70% of the patients in each group, with the majority of patients having either stage II or III disease, and most patients underwent laparoscopic procedures. However, the stage, tumor location, serum albumin, surgical approach, neoadjuvant chemotherapy history, and rectal resection proportion were significantly different between the groups. All these baseline characteristics are shown in Table [1](#Tab1){ref-type="table"}. Table 1Characteristics and incidence of postoperative complications for OA + MBP and MBP groupsOA + MBPMBP*p* valueNumber255326Age59.78 ± 12.1159.22 ± 12.160.583Gender (male/female)145/110199/1270.309BMI22.40 ± 3.5922.93 ± 3.400.066Approach (open/lap)46/20925/301\< 0.05Surgical time (min)199.59 ± 70.50205.55 ± 60.460.274ASA (1/2/3/4)145/93/17/0178/107/41/00.053Stage (1/2/3/4)34/101/67/5345/135/108/380.019Neoadjuvant chemotherapy746\< 0.05Colon/rectum240/15237/89\< 0.05Albumin39.13 ± 4.2840.33 ± 5.490.04Postoperative LOS (day)10.10 ± 5.199.20 ± 5.010.03Expenses (kRMB)56.74 ± 16.6066.73 ± 25.66\< 0.05Anastomotic fistula3100.126SSIs27 (100%)54 (100%)0.03 Superficial12 (44.4%)26 (48.1%)0.114 Deep3 (11.1%)9 (16.7%)0.182 Space12 (44.4%)19 (35.2%)0.55Ileus16100.06Urinary infection310.324CDI8100.962Pulmonary infection17110.066Post-hemorrhage111DVT020.507Readmission6110.621*BMI* body mass index, *ASA* American Society of Anesthesiologists grading, *LOS* length of stay, *CDI Clostridium difficile* infection, *SSIs* surgical site infections *DVT* deep vein embolism

Unmatched case results {#Sec8}
----------------------

Postoperative complications within 30 days were reviewed using the patient database. Postoperative LOS was significantly longer in the OA + MBP group (10.10 ± 5.19 vs 9.20 ± 5.01 days; *p* = 0.03), while the expenses were significantly greater in the MBP group (56.74 ± 16.60 vs 66.73 ± 25.66 kRMB; *p* \< 0.05). The overall SSI incidence was significantly lower in the OA + MBP group (27 vs 54, *p* = 0.03 s), while rates of other complications such as anastomotic leakage, ileus, pulmonary infection, diarrhea, DVT, and hemorrhage were comparable between both groups, as shown in Table [1](#Tab1){ref-type="table"}.

Characteristics of the propensity score-matched samples {#Sec9}
-------------------------------------------------------

As retrospective data, bias inherent in these patient groups may influence study outcomes. To better control confounding variables and achieve comparable distributions of TNM stage, surgical approach, ASA score, gender, BMI, tumor location, and neoadjuvant chemotherapy history, patients were matched 1:1 based on those factors using SPSS. The propensity score-matched sample was comprised of 428 patients (214 in each group). After matching, all variants were similar between both groups as shown in Table [2](#Tab2){ref-type="table"}. Table 2Characteristics and incidence of postoperative complications for propensity matched OA + MBP and MBP groupsOA + MBPMBP*p* valueNumber214214Age59.37 ± 11.7659.36 ± 12.110.994Gender (male/female)120/94118/960.931BMI22.66 ± 3.6322.42 ± 3.290.468Approach (open/lap)18/19622/1920.691Surgical time (min)196.79 ± 68.72202.06 ± 55.630.384ASA (1/2/3/4)113/85/16/0127/68/19/00.227Stage (1/2/3/4)31/91/57/3522/93/76/230.08Neoadjuvant chemotherapy771Colon/rectum200/14190/240.089Albumin39.43 ± 4.2340.15 ± 5.260.124Postoperative LOS (day)9.71 ± 4.939.08 ± 4.970.192Expenses (kRMB)56.98 ± 16.5865.27 ± 20.130.000Anastomotic fistula240.685SSIs15 (100%)34 (100%)0.004Superficial5 (33.3%)15 (44.1%)0.03Deep2 (13.3%)5 (14.7%)0.449Space8 (53.3%)14 (41.2%)0.189Ileus1070.458Urinary infection211CDI780.793Pulmonary infection1250.135Post-hemorrhage101DVT011Readmission431*BMI* body mass index, *ASA* American Society of Anesthesiologists grading, *LOS* length of stay, *CDI Clostridium difficile* infection, *SSIs* surgical site infections, *DVT* deep vein embolism

Results of the propensity score-matched sample {#Sec10}
----------------------------------------------

The matched data exhibited consistent results with respect to SSI incidence, with 15 and 35 cases in the OA + MBP and MBP alone groups, respectively (*p* \< 0.05). There was also a significant difference in the rates of superficial SSI (5 vs 15 cases; *p* = 0.03), and total expense remained significantly different between groups (56.98 ± 16.58 vs 65.27 ± 20.13 kRMB; *p* \< 0.05). The postoperative LOS no longer remained significantly different between groups after adjustment (9.71 ± 4.93 vs 9.08 ± 4.97 days, *p* = 0.192). Other outcomes remained comparable, as shown in Table [2](#Tab2){ref-type="table"}.

Subgroup analysis {#Sec11}
-----------------

To further explore the site-specific benefits of OA, all patients were subdivided into right hemi-colon and left-side colon or rectum subgroups, while patients that underwent transverse colectomies were excluded, after which propensity matching was performed. A total of 114 patients were included in the right hemi-colon subgroup. Patient baseline characteristics were comparable between the two groups. All postoperative outcomes were similar except expense (58.46 ± 21.29 vs 66.15 ± 14.44 kRMB; *p* = 0.03). Characteristics and results are shown in Table [3](#Tab3){ref-type="table"}. Table 3Characteristics and postoperative complications incidence of the propensity matched data in right hemicolectomy subgroupOA + MBPMBP*p* valueNumber5757Age57.93 ± 11.4359.28 ± 12.190.543Gender (male/female)30/2733/240.572BMI22.88 ± 3.1621.96 ± 3.350.135Approach (open/lap)8/499/480.793Surgical time (min)216.65 ± 82.23207.71 ± 46.470.477ASA (1/2/3/4)26/24/725/25/70.980Stage (1/2/3/4)7/24/16/103/28/20/60.340Neoadjuvant chemotherapy111Albumin39.10 ± 4.4038.29 ± 5.5590.397Postoperative LOS (day)10.09 ± 6.919.51 ± 3.790.58Expenses (kRMB)58.46 ± 21.2966.15 ± 14.440.03Anastomotic fistula101SSIs7 (100%)9 (100%)0.590 Superficial1 (14.3%)3 (33.3%)0.618 s Deep1 (14.3%)2 (22.2%)1 Space5 (71.4%)4 (44.4%)1Ileus300.243Urinary infection101CDI020.496Pulmonary infection630.490Readmission101*BMI* body mass index, *ASA* American Society of Anesthesiologists grading, *LOS* length of stay, *CDI Clostridium difficile* infection, *SSIs* surgical site infections, *DVT* deep vein embolism

Left-side colon or rectum subgroup included left colectomy, sigmoid colectomy, and rectal resection patients. The SSI incidence and superficial SSI incidence were statistically different between both groups (13 vs 31, *p* = 0.004 and 7 vs 17, *p* = 0.032, respectively). The total expense was also higher in the MBP group (54.25 ± 14.25 vs 67.67 ± 34.68, *p* \< 0.05), as shown in Table [4](#Tab4){ref-type="table"}. Table 4Characteristics and postoperative complications incidence of the propensity matched data in left-side colon or rectum subgroupOA + MBPMBP*p* valueNumber124124Age60.81 ± 12.0060.04 ± 11.250.605Gender (male/female)77/4766/580.157BMI22.95 ± 3.3523.42 ± 3.400.268Approach (open/lap)6/11812/1120.142Surgical time (min)189.67 ± 63.71199.86 ± 60.770.200ASA (1/2/3/4)68/48/869/37/180.071Stage (1/2/3/4)22/47/34/2119/48/38/190.907Neoadjuvant chemotherapy460.749Albumin40.07 ± 3.8840.99 ± 5.290.12Postoperative LOS (day)9.79 ± 4.689.89 ± 6.210.881Expenses (kRMB)54.25 ± 14.2567.67 ± 34.68\< 0.05Anastomotic fistula250.446SSIs13 (100%)31 (100%)0.004 Superficial7 (53.8%)17 (54.9%)0.032 Deep1 (7.7%)5 (16.1%)0.213 Space5 (38.5%)9 (29.0%)0.271Ileus860.582Urinary infection211CDI530.722Pulmonary infection321Readmission310.622*BMI* body mass index, *ASA* American Society of Anesthesiologists grading, *LOS* length of stay, *CDI* C*lostridium difficile* infection, *SSIs* surgical site infections, *DVT* deep vein embolism

To further analyze risk factors affecting SSI incidence, multivariate logistic regression was performed to evaluate the following parameters: ASA stage, age \> 60, gender, surgical approach (laparoscopic approach), surgical time \> 4 h, stage over II, application of preoperative OA, and low albumin levels. We found that age \> 60 and surgical time \> 4 h were independent risk factors for SSIs, whereas application of preoperative OAs was a protective factor reducing the incidence of SSIs as shown in Table [5](#Tab5){ref-type="table"}. Table 5Logistic regression model to identify factors independently associated with surgical site infectionsSE*Bp* valueOR95% CIAge \> 600.3090.7390.0172.0931.1433.833Time \> 4 h0.3080.9930.0012.6981.4724.944OA + MBP0.336− 1.0070.0020.3650.1920.693*OA* oral antibiotics, *MBP* mechanical bowel preparation, *SE* standard error, *OR* odds ratio, *CI* confidence interval

Discussion {#Sec12}
==========

Surgical site infection is one of the most common complications after colorectal surgery, substantially increasing patient morbidity and expenses \[[@CR1]--[@CR3]\]. With the large burden of bacteria in the bowel, elective colorectal resections are associated with particularly high rates of SSIs \[[@CR2], [@CR4]\]. Bowel preparation modes prior to elective colorectal surgery have been varied for decades and aim to reduce the SSIs \[[@CR8]--[@CR14], [@CR18]\].

MBP was initially performed preoperatively with the goal of reducing bacterial burden and human fecal content and to thereby decrease SSI rates \[[@CR6]\]. However, as mentioned above, subsequent research demonstrated that MBP alone failed to achieve this objective \[[@CR2], [@CR6]\], instead causing paradoxical complications \[[@CR11]--[@CR14]\]. It has been proposed that when implemented in concert with OA administration, the MBP-mediated reduction in bacterial burden may guarantee better OA delivery to the entire length of the colon, improving prophylactic activity \[[@CR19]--[@CR22]\]. Furthermore, with the advent of the ERAS era, surgeons have sought to minimize perioperative physiologic perturbations, leading to increasing concern regarding and abandonment of the use of MBP or OA. One such concern is that the combinational preparation may prolong preoperative hospital stays and expenses, in addition to causing increased patient discomfort and reduced compliance. As such, there is a need to determine whether the combination of MBP + OA yields better patient outcomes. Recently, the combination of OA and MBP has been evaluated in several retrospective studies which demonstrated a significant decrease in the rate of SSIs \[[@CR15]--[@CR17]\]. However, dietary structure, BMI, lifestyle, and colonic flora differ between people from Eastern and Western nations. Furthermore, no previous studies have evaluated the value of OA in a site-specific manner in the colon/rectum. As such, we performed a propensity matching retrospective study with subgroup analyses in order to further evaluate the prophylactic value of OA.

The current study revealed that the application of MBP + OA can significantly decrease the overall incidence of SSIs (10.59% vs 16.56%, *p* = 0.03) and expenses (56.74 ± 16.60 vs 66.73 ± 25.66 kRMB, *p* \< 0.05) relative to MBP alone in patients undergoing elective colorectal resection. However, postoperative LOS was longer in the MBP + OA group (10.10 ± 5.19 days vs 9.20 ± 5.01 days, *p* = 0.03). The incidence of anastomotic fistula, postoperative ileus, urinary infection, *Clostridium difficile* infection, pulmonary infection, hemorrhage, DVT, and 30-day readmission was comparable in both groups. Owing to the retrospective nature of this analysis, several patient baseline characteristics were different between groups, including serum albumin, surgical approach, neoadjuvant chemotherapy history, and rectal resection proportion, potentially confounding our results. As such, a propensity score matching analysis was conducted to normalize patient groups according to TNM stage, surgical approach, ASA score, gender, BMI, tumor location, and neoadjuvant chemotherapy history with a 1:1 ratio. This led us to analyze a total of 428 patients in the final data analysis, which revealed that overall SSI incidence (7.01% vs 15.89%, *p* = 0.004), superficial SSI incidence (2.34% vs 7.01%, *p* = 0.03), and hospitalization expense (56.98 ± 16.58 vs 65.27 ± 20.13 kRMB, *p* \< 0.05) were significantly higher in the MBP alone group. Postoperative LOS was comparable between both groups, potentially because patients with superficial SSI were first discharged and undergoing outpatient wound care, potentially influencing the LOS results in our center.

Previous studies have indicated that in the right hemi-colon, the concentration of bacteria ranges from 10^6^ to 10^7^ bacteria/g of stool content, whereas these numbers rise to 10^11^--10^12^ bacteria/g in the rectosigmoid region \[[@CR6], [@CR19]\]. Several studies have demonstrated a lower risk of SSIs for right colon resections \[[@CR23], [@CR24]\]. Therefore, the proposal to forgo the use of OA prior to right hemicolectomy was raised in the ERAS era, without formal demonstration of the outcomes of such an approach. Hence, in the present study, we performed for the first time a stratified propensity analysis of patient outcomes for right hemicolectomy and left-side (descending, sigmoid colon, and rectum) colorectal resection subgroups. The preventative function was especially prominent in left-side patients, in whom the incidence of overall SSIs (7.01% vs 15.89%, *p* = 0.004), superficial SSI (2.34% vs 7.01%, *p* = 0.03), and hospitalization expenses (56.98 ± 16.58 vs 65.27 ± 20.13 kRMB, *p* \< 0.05) were significantly higher relative to the MBP alone group. However, similar improvements in outcomes upon OA administration were not observed in the right hemicolectomy subgroup. These findings are consistent with previous proposals, underscoring the need to tailor bowel preparation strategies based on the surgical site in a given patient.

Our logistic regression model demonstrated that SSI incidence was associated with age, surgical duration, and the application of OA. Together our findings demonstrate the key value of OA in bowel preparation for patients undergoing colorectal surgery, suggesting that individual preoperative evaluation may help avoid unnecessary bowel preparation and minimize postoperative morbidity.

There are several strengths to our study. Our detailed database provided us with a sufficient sample size to analyze the association between bowel preparation mode and postoperative outcomes. The propensity analysis helped minimize the bias in the baseline characteristics of enrolled patients and thus enhanced the generalizability of our findings. However, several limitations still exist in our trial. First, this was a single-institution study, which limits its external validity. Second, the bowel preparation modes were reviewed through the database and medical records, and as such, the compliance and quality could not be evaluated. Third, as in other retrospective studies, historical bias may still exist despite our propensity analysis.

With increasing adoption of ERAS, fewer patients will undergo bowel preparations. However, as this was a retrospective analysis, all reviewed patients were from an era prior to ERAS application. Therefore, comparisons between no bowel preparation, simple MBP, OA + MBP, and simple OA could not be conducted. We are now in the process of conducting a randomized controlled trial of the effects of MBP + OA compared with MBP alone (NCT03856671). With the application of ERAS, future assessments of patients who receive no MBP or simple OA will be conducted, thereby helping to overcome the limitations of the present study.

Conclusion {#Sec13}
==========

The combination of oral antibiotics and mechanical bowel preparation was associated with a significant decrease in the overall incidence of SSIs, superficial SSI, and hospitalization expenses. MBP + OA is therefore recommended, especially in patients undergoing left-side colon or rectum resections given its clear prophylactic efficacy. The MPB + OA combination provided no clear benefit in right hemi-colon resection patients. Age, surgical duration, and application of OA were independent factors that affected the rate of SSI occurrence.
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